ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646395 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646395; 2) Community: the network communities that were significantly associated with the response to NSC 646395; 3) Molecule: the relationships between components within communities and NSC 646395; 4) MDR: the compounds that were significantly associated with the NSC 646395.

NSC Compound Enrichment Correlation
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0138010872611484 0.18839868
NSC 740 Methotrexate 0.0138010872611484 0.13689341
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0138010872611484 0.18826796
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0138010872611484 0.36658076
NSC 255104 Des-O-methylgeldanamycin 0.0138010872611486 0.44348528
NSC 268242 N,N-Dibenzyldaunorubicin 0.0138010872611486 0.18615368
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.0138010872611486 0.25515103
NSC 30916 MP 317 0.0138010872611486 0.25754256
NSC 349644 CYANOCYCLINE A (CHUGAI) 0.0138010872611486 0.19708705
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0138010872611486 0.23661407
Total:99  Current:33    [First] [Prev] [Next] [Last]